| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Gain on extinguishment of debt | 3 | 178 | - | - |
| Foreign exchange and other | -7 | -30 | -4 | - |
| Income (loss) before income taxes | 218 | 140 | -47 | -21 |
| Provision for income taxes | 37 | 12 | 39 | 71 |
| Net income (loss) | 181 | 128 | -86 | -92 |
| Net (income) loss attributable to noncontrolling interest | 2 | -20 | -28 | -7 |
| Net income (loss) attributable to bausch health companies inc | 179 | 148 | -58 | -85 |
| Basic earnings (loss) per share attributable to bausch health companies inc. (in dollars per share) | 0.48 | 0.4 | -0.16 | -0.23 |
| Basic weighted-average common shares (in shares) | 371,300,000 | 370,900,000 | 369,600,000 | 368,400,000 |
| Diluted earnings (loss) per share attributable to bausch health companies inc. (in dollars per share) | 0.48 | 0.4 | -0.16 | -0.23 |
| Diluted weighted-average common shares (in shares) | 375,500,000 | 373,100,000 | 369,600,000 | 368,400,000 |
Bausch Health Companies Inc. (BHC)
Bausch Health Companies Inc. (BHC)